GlassScriptPhysician profile
Yury Malyshev
NPI 1831553213
$25,457.80
in general payments reported to CMS, 2019-2025
15 companies · $6,536 in 2025
The $6,536 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $4,081 · 2023: $11K · 2024: $3,543 · 2025: $6,536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,545 · Grant: $6,500 · Travel and Lodging: $5,887 · Education: $445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,544.56 |
| Grant | $6,500.00 |
| Travel and Lodging | $5,887.18 |
| Education | $444.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $12,093.17 | 2022-2025 | Lux-Dx Insertable Cardiac Monitor, Emblem Mri S-Icd, Farapulse |
| Biotronik INC. | $5,304.88 | 2023-2025 | Acticor 7 Vr-T Dx, Renamic Neo, Biomonitor |
| Medtronic, INC. | $4,877.21 | 2022-2025 | Cobalt Dr Mri Surescan, Micra, Azure Xt Dr Mri Surescan |
| Abbott Laboratories | $1,412.37 | 2023-2025 | Aveir, Jot Dx, Assurity |
| Biosense Webster, INC. | $561.92 | 2024 | Carto 3 |
| Kestra Medical Technology Services, INC. | $413.84 | 2024-2025 | Assure Wcd |
| Cardiva Medical, INC. | $205.25 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 5f Vcs |
| Angiodynamics, INC. | $186.33 | 2023-2024 | Alphavac |
| Baxter Healthcare | $149.33 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Ebr Systems, INC. | $97.57 | 2025 | |
| Cordis US Corp. | $45.92 | 2025 | Mynx Control Venous |
| Cortex, INC. | $42.73 | 2024 | |
| Alnylam Pharmaceuticals INC. | $24.97 | 2025 | Amvuttra |
| E.R. Squibb & Sons, L.L.C. | $24.01 | 2022 | |
| Philips North America LLC | $18.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yury Malyshev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.